某院抗肿瘤辅助用药医嘱点评分析  

Review and Analysis of Medical Orders of Anti-Tumor Adjutant Drugs in a Hospital

作　　者：秦颖 高柏青[1] 

机构地区：[1]内蒙古医科大学第三附属医院药学部,内蒙古包头014010

出　　处：《中国药业》2017年第9期85-87,共3页China Pharmaceuticals

摘　　要：目的了解医院抗肿瘤辅助用药使用情况,为临床合理用药提供参考。方法利用医院合理用药系统(PASS),选取医院2016年7月至12月抗肿瘤辅助用药病历801份,对抗肿瘤辅助用药医嘱进行点评。结果 801份病历中,有240份存在不合理用药,合理率为70.04%;不合理用药主要表现为适应证不适宜、用法用量不适宜、溶剂选择不适宜及联合用药不适宜等;抗肿瘤辅助用药金额排名前10位医嘱点评合格率最高的为斑蝥维生素B6注射液(98.36%),合格率最低的为磷酸肌酸钠注射液(52.34%)。结论医院抗肿瘤辅助用药存在不合理使用情况,应加强用药干预及行政监督,以规范抗肿瘤辅助用药的临床应用。Objective To investigate the utilization of anti- tumor adjuvant drugs to provide references for rational use in the clinical. Methods Based on clinical pharmacy management system（SPSS）, 801 cases of anti- tumor adjuvant medication were selected and reviewed from July 2016 to November in our hospital. Results Among 801 medical records, there were 240 irrational medical records of anti -tumor adjutant drugs, with qualified rate of 70. 04%. The types of irrational drag use were inappropriate of indication, dosage, solvent and drug combination. Among Top 10 of anti-tumor adjutant drugs in the list of amount ranking, the qualified rate of Can- tharidinate and Vitamin B6 Injection was the highest（98.36% ）, Phosphocreatine Sodium was the lowest（52.34% ）. Conclusion It has irrational use of anti- tumor adjuvant medication in our hospital, we should strengthen the use of drug intervention and administrative supervision to standardized the management for rational drug use.

关 键 词：抗肿瘤辅助用药 医嘱点评 合理用药 

分 类 号：R969.3[医药卫生—药理学] R979.1[医药卫生—药学]